Intrinsic Value of S&P & Nasdaq Contact Us

Asensus Surgical, Inc. ASXC NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.50
+331.2%

Financial Health Score — ASXC

Asensus Surgical, Inc. (ASXC) has an overall financial health rating of C with a composite score of 0 out of 5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2024-08-21.

C
Overall Rating
2024-08-21

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2024-08-21 C -/5 -/5 -/5 -/5 -/5 -/5
2024-08-20 C -/5 -/5 -/5 -/5 -/5 -/5
2024-08-19 C -/5 -/5 -/5 -/5 -/5 -/5
2024-08-16 C -/5 -/5 -/5 -/5 -/5 -/5
2024-08-15 C -/5 -/5 -/5 -/5 -/5 -/5
2024-08-14 C -/5 -/5 -/5 -/5 -/5 -/5
2024-08-13 C- -/5 -/5 -/5 -/5 -/5 -/5
2024-08-12 C- -/5 -/5 -/5 -/5 -/5 -/5
2024-08-09 C- -/5 -/5 -/5 -/5 -/5 -/5
2024-08-08 C- -/5 -/5 -/5 -/5 -/5 -/5
2024-08-07 C- -/5 -/5 -/5 -/5 -/5 -/5
2024-08-06 C- -/5 -/5 -/5 -/5 -/5 -/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message